Change In Demographic Profile of Carcinoma Endometrium – An Analysis from A Tertiary Care Centre
Keywords:
carcinoma endometrium, demographic trends, histopathology, FIGO stage, India, lymphovascular invasionAbstract
Background: The incidence of carcinoma endometrium is rising worldwide, with marked demographic shifts driven by urbanisation, longevity and metabolic disease. Indian data remain sparse, particularly on the interplay between sociodemographic factors and aggressive histotypes.
Methods: We performed a retrospective cross‑sectional review of 25 consecutive women managed for carcinoma endometrium between August 2022 and August 2024 in a tertiary referral hospital in southern India. Demographic variables, reproductive history, socioeconomic status, imaging, histopathology (WHO 2014) and Fédération Internationale de Gynécologie et d’Obstétrique (FIGO 2018) stage were abstracted. Descriptive statistics, χ² tests and Pearson correlations explored associations; significance was set at p < 0.05.
Results: Median age was 58 years (IQR 52–65); 72 % were post‑menopausal and 84 % multiparous. A lower‑socioeconomic background characterised 72 % of patients. Endometrioid carcinoma predominated (64 %), but high‑risk subtypes—serous and clear‑cell—collectively accounted for 28 %. One‑fifth of tumours were poorly differentiated (Grade III). Advanced (Stage III–IV) disease presented in 32 % of women. Tumour grade correlated significantly with lymphovascular invasion (r = 0.62, p < 0.001), and serous histology correlated with advanced stage (r = 0.68, p < 0.01).
Conclusion: Even in a small cohort, a clear shift towards aggressive histology and late‑stage presentation is evident, disproportionately affecting socio‑economically disadvantaged women. Early detection strategies, equitable access to care and integration of molecular testing are imperative to curb morbidity
Downloads
References
Amant, F., Moerman, P., Neven, P., Timmerman, D., Van Limbergen, E., & Vergote, I. (2005). Endometrial cancer. The Lancet, 366(9484), 491–505. https://doi.org/10.1016/S0140 6736(05)67063 8 NCBI
Bakkar, R., Samara, M., Al Taani, M. I., Haddad, H., Alkhatib, H. S., & Alhalaseh, Y. (2021). Prognostic impact of lymphovascular space invasion in endometrioid endometrial cancer: A meta analysis. Journal of Gynecologic Oncology, 32(6), e84. https://doi.org/10.3802/jgo.2021.32.e84 JGO Journal of Gynecologic Oncology
Bosse, T., Peters, E. E., Creutzberg, C. L., Jürgenliemk Schulz, I. M., Jobsen, J. J., Mens, J. W. M., et al. (2015). Substantial lymph vascular space invasion is a significant risk factor for recurrence in endometrial cancer—a pooled analysis of PORTEC 1 and 2 trials. European Journal of Cancer, 51(13), 1742–1750. https://doi.org/10.1016/j.ejca.2015.05.015 Frontiers
Colombo, N., Creutzberg, C., Amant, F., Bosse, T., González Martín, A., Ledermann, J., et al. (2016). ESMO–ESGO–ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow up. Annals of Oncology, 27(1), 16–41. https://doi.org/10.1093/annonc/mdv484 Groningen Research Portal
Crosbie, E. J., Kitson, S. J., McAlpine, J. N., Mukhopadhyay, A., Powell, M. E., & Singh, N. (2022). Endometrial cancer. The Lancet, 399(10333), 1412–1428. https://doi.org/10.1016/S0140 6736(22)00323 3 The Lancet
Denschlag, D., Ulrich, U., & Emons, G. (2011). The diagnosis and treatment of endometrial cancer—progress and controversies. Deutsches Ärzteblatt International, 108(34–35), 571–577. https://doi.org/10.3238/arztebl.2011.0571 Göttingen Research Online
Dou, Y., Kawaler, E. A., Cui Zhou, D., Gritsenko, M. A., Huang, C., Blumenberg, L., et al. (2020). Proteogenomic characterization of endometrial carcinoma. Cell, 180(4), 729–748.e26. https://doi.org/10.1016/j.cell.2020.01.026 Europe PMC
Evans, T., Sany, O., Pearmain, P., Ganesan, R., Blann, A., & Sundar, S. (2011). Differential trends in the rising incidence of endometrial cancer by type: Data from a UK population based registry from 1994 to 2006. British Journal of Cancer, 104(9), 1505–1510. https://doi.org/10.1038/bjc.2011.68 UK Health Security Agency
Felix, A. S., Yang, H. P., Bell, D. W., & Sherman, M. E. (2017). Epidemiology of endometrial carcinoma: Etiologic importance of hormonal and metabolic influences. In Advances in Experimental Medicine and Biology (Vol. 943, pp. 3–46). Springer. https://doi.org/10.1007/978 3 319 43139 0_1 Mayo Clinic
Lortet Tieulent, J., Ferlay, J., Bray, F., & Jemal, A. (2018). International patterns and trends in endometrial cancer incidence, 1978–2013. Journal of the National Cancer Institute, 110(4), 354–361. https://doi.org/10.1093/jnci/djx214 BCU Library Search
Malhotra, N., Taneja, A., Nanda, S., & Gupta, P. (2020). Changing trends in gynecological cancers in India: A clinicopathological analysis. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 9(4), 1681–1685. DOI not assigned/available
Morice, P., Leary, A., Creutzberg, C., Abu Rustum, N., & Darai, E. (2016). Endometrial cancer. The Lancet, 387(10023), 1094–1108. https://doi.org/10.1016/S0140 6736(15)00130 0 NCBI
Raj, F. A., Padmakumar, D., Selvam, P., & Ajmal, I. T. (2024). Primary extrapelvic umbilical endometriosis presenting with cyclical umbilical bleeding: A case report. Cureus, 16(7), e65473. https://doi.org/10.7759/cureus.65473
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
